These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7153848)

  • 21. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
    Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
    Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erratum: Relaxation of catch in a molluscan smooth muscle. II. Effects of serotonin, dopamine and related compounds.
    Twarog BM; Cole RA
    Comp Biochem Physiol A Comp Physiol; 1973 Dec; 46(4):831-5. PubMed ID: 4148171
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of ergot alkaloids with dopaminergic receptors in the rat striatum and nucleus accumbens.
    Spano PF; Trabucchi M
    Gerontology; 1978; 24 Suppl 1():106-14. PubMed ID: 618775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic activity of some ergot alkaloid derivatives: relationship to their chemical structure.
    Soskić V; Petrović J; Trajković D; Kidric M
    Pharmacology; 1986; 32(3):157-66. PubMed ID: 2938196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of ergot alkaloids in clinical use.
    Berde B
    Med J Aust; 1978 Nov; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E
    Gen Pharmacol; 1983; 14(1):95-102. PubMed ID: 6826043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of sinusoidal vibrations on tension and stiffness in Mytilus smooth muscle during catch state.
    Kobayashi T; Ichikawa C; Sugi H
    Jpn J Physiol; 1985; 35(4):689-92. PubMed ID: 4068374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The affinities of ergot compounds for dopamine agonist and dopamine antagonist receptor sites.
    Goldstein M; Lew JY; Sauter A; Lieberman A
    Adv Biochem Psychopharmacol; 1980; 23():75-82. PubMed ID: 7395625
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.
    Watanabe H; Somei M; Sekihara S; Nakagawa K; Yamada F
    Jpn J Pharmacol; 1987 Dec; 45(4):501-6. PubMed ID: 3127619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ergot alkaloids and cyclic nucleotides in the CNS.
    Trabucchi M; Hofmann M; Montefusco O; Spano PF
    Pharmacology; 1978; 16 Suppl 1():150-55. PubMed ID: 205889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of dopaminergic ergot derivatives with cyclic nucleotide system.
    Spano PF; Saiani L; Memo M; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 23():95-102. PubMed ID: 6249093
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposed dopaminergic pharmacophore of lergotrile, pergolide, and related ergot alkaloid derivatives.
    Cannon JG; Demopoulos BJ; Long JP; Flynn JR; Sharabi FM
    J Med Chem; 1981 Mar; 24(3):238-40. PubMed ID: 6115056
    [No Abstract]   [Full Text] [Related]  

  • 35. LSD labels a novel dopamine receptor in molluscan nervous system.
    Drummond AH; Bucher F; Levitan IB
    Nature; 1978 Mar; 272(5651):368-70. PubMed ID: 24805
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology of FMRFamide in Mytilus catch muscle.
    Muneoka Y; Saitoh H
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(1):207-14. PubMed ID: 2877791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
    Longo VG; Loizzo A
    Pharmacology; 1978; 16 Suppl 1():189-92. PubMed ID: 643900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxation of catch in a molluscan smooth muscle. II. Effects of serotonin, dopamine and related compounds.
    Twarog BM; Cole RA
    Comp Biochem Physiol A Comp Physiol; 1972 Oct; 43(2):331-5. PubMed ID: 4145244
    [No Abstract]   [Full Text] [Related]  

  • 39. General pharmacology of ergot alkaloids.
    Boissier JR
    Pharmacology; 1978; 16 Suppl 1():12-26. PubMed ID: 205888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin and dopamine as neurotransmitters in mytilus: block of serotonin receptors by an organic mercurial.
    Twarog BM; Muneoka Y; Ledgere M
    J Pharmacol Exp Ther; 1977 May; 201(2):350-6. PubMed ID: 16121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.